跳至主要内容
临床试验/NCT05423028
NCT05423028招募中不适用

The Effects of Vitamin B12 and Dextrose on the Ultrasound-guided Median Nerve Hydrodissection

National Cheng-Kung University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年12月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Change of Boston Carpal Tunnel Syndrome Questionnaire

研究概览

简要总结

Carpal tunnel syndrome is the most common peripheral entrapment neuropathy of the upper limb. Previous experiments found that ultrasound-guided median nerve hydrodissection with 5% dextrose water could ameliorate the condition of carpal tunnel syndrome. Oral administration of vitamin B 12 had been reported to reduce the discomfort from peripheral neuropathy although the level of evidence is not strong. This prospective, double-blind randomized control trial aims to compare the effects of different kinds of the injection agents on carpal tunnel syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 20-80 year-old.
  • Diagnosis (carpal tunnel syndrome) was confirmed using an electrophysiological study.

排除标准

  • Previously undergone wrist surgery or steroid injection for CTS
  • Thrombocytopenia
  • Coagulopathy
  • Inflammation status
  • Polyneuropathy
  • Brachial plexopathy
  • Cervical radiculopathy
  • Autoimmune disease
  • Malignancy
  • Pregnancy
  • Thoracic outlet syndrome

研究组 & 干预措施

Dextrose

Active Comparator

干预措施: Ultrasound-guided nerve hydrodissection (Procedure)

Dextrose + Vitamin B12

Experimental

干预措施: Ultrasound-guided nerve hydrodissection (Procedure)

Vitamin B12

Experimental

干预措施: Ultrasound-guided nerve hydrodissection (Procedure)

结局指标

主要结局

Change of Boston Carpal Tunnel Syndrome Questionnaire

时间窗: Pre-treatment, 1st, 3rd, 6th month after injection

Measure the severity of symptoms and functional status before and after treatment

次要结局

  • Cross-sectional area of the median nerve(Pre-treatment, 1st, 3rd, 6th month after injection)
  • Median nerve conduction velocity and amplitude(Pre-treatment, 1st, 6th month after injection)
  • Visual analog scale of pain and tingling(Pre-treatment, 1st, 3rd, 6th month after injection)
  • Median nerve elastography(Pre-treatment, 1st, 3rd, 6th month after injection)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验